Ireland - English - HPRA (Health Products Regulatory Authority)

hameln pharmaceuticals gmbh - dobutamine hydrochloride - solution for infusion - 5 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dobutamine hydrochloride 12.5 mg/ml - solution for injection - 12.5 mg/ml - active: dobutamine hydrochloride 12.5 mg/ml excipient: sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. (refer to the data sheet for conditions which may precipitate such situations).

Ireland - English - HPRA (Health Products Regulatory Authority)

ever valinject gmbh - dexmedetomidine hydrochloride - concentrate for solution for infusion - 100 microgram(s)/millilitre - other hypnotics and sedatives; dexmedetomidine

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - dexmedetomidine hydrochloride - concentrate for solution for infusion - 100 microgram(s)/millilitre - dexmedetomidine

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - dexmedetomidine hydrochloride - concentrate for solution for infusion - 100 microgram(s)/millilitre - dexmedetomidine

United States - English - NLM (National Library of Medicine)

general injectables and vaccines, inc. - dobutamine hydrochloride (unii: 0wr771djxv) (dobutamine - unii:3s12j47372) - dobutamine injection is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of adults with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures. in patients who have atrial fibrillation with rapid ventricular response, a digitalis preparation should be use prior to institution of therapy with dobutamine hydrochloride. dobutamine hydrochloride is contraindicated in patients with idiopathic hypertrophic subaortic stenosis and in patients who have shown previous manifestations of hypersensitivity to dobutamine injection.

Ireland - English - HPRA (Health Products Regulatory Authority)

flynn pharma ltd - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - dobutamine hcl eqv dobutamine - injection - 12.5 mg/ml - dobutamine hcl eqv dobutamine 12.5 mg/ml

Malta - English - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

Malta - English - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy